Boston Scientific’s Farapulse matches Medtronic cryoablation in trial
Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.
MedPage Today on MSN3d
Pulsed Field Ablation an Option to Prevent Recurrence of Atrial Tachyarrhythmia
Pulsed field ablation (PFA) was noninferior to cryoballoon ablation for the incidence of a first recurrence of atrial ...
MedTech Dive3d
3 takeaways from ACC 2025
Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.
Cryofocus Medtech (Shanghai) Co., Ltd.: Cryofocus Medtech: Steady Increase in Revenue and Gross Profit with Solid R&D Expenditures in 2024
Nearly 10 Product Candidates Under Development are Expected to be Commercialized in the Next Three YearsHONG KONG, Apr 1, 2025 - (JCN Newswire) - Cryofocus Medtech (Shanghai) Co., Ltd. ('Cryofocus Med ...
JCN Newswire5d
Cryofocus Medtech: Steady Increase in Revenue and Gross Profit with Solid R&D Expenditures in 2024
In 2024, Cryofocus Medtech’s revenue has maintained a strong growth trend within the interventional cryotherapy industry. The total revenue of Cryofocus Medtech increased by 30.7% YoY to RMB53.5 ...
MassDevice5d
Boston Scientific Farapulse PFA system shows superiority in head-to-head study with Medtronic cryoablation system
Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...